Macroaxis: Personalized Investing

Personalized Investing and

Digital Wealth Optimization

Benchmark  United States  NYSE  11,063   19.31 Index Moved Down -0.17%  

Collecting data for DGM

Diagnostic valuation Diagnostic valuation

2.38 times
Diagnostic seems to be over valued based on Macroaxis valuation methodology. Macroaxis computes value of Diagnostic Medical S from reviewing the firm fundamentals such as Operating Margin of (0.94)%, Profit Margin of (4.08)% and Current Valuation of 14.88M as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.
Investment horizon:  
  30 Days    Login   to change

Diagnostic Total Value Analsys

Diagnostic Medical Systems SA is currently anticipated to have takeover price of 14.88 M with market capitalization of 15.01 M, debt of 2.71 M, and cash on hands of 2.84 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Diagnostic fundamentals before making investing decisions based on the enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
14.88 M15.01 M2.71 M2.84 M

Diagnostic Investor Information

The company has price-to-book (P/B) ratio of 1.19. Some equities with similar Price to Book (P/B) outperform the market in the long run. Diagnostic Medical Systems SA recorded loss per share of 0.01. This company had not issued any dividends in recent years. Diagnostic Medical Systems S.A. manufactures and distributes imaging systems for conventional and digital radiology, and bone densitometry applications worldwide. To learn more about DMS call Jean-Paul Ansel at 33 4 67 50 49 00 or check out

Diagnostic Asset Utilization

Diagnostic Medical Systems SA shows negative operation of assets of -0.67 percent, getting only €0.01 for each euro of assets held by the firm. Unsuccessful assets utilization denotes the company is being less effective with each euro of assets it shows. In plain English assets utilization of Diagnostic Medical Systems SA shows how unproductive it operates for each euro spent on its assets.

Diagnostic Profitability Analysis

The company reported revenue of 23.51 M. Net Loss for the year was (959 K) with profit before overhead, payroll, taxes, and interest of 8 M.
Benchmark  Embed   Values 

Diagnostic Debt Analysis

DMS has accumulated about 2.84 M in cash with 112 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
The company has accumulated 2.71 M in total debt with debt to equity ratio (D/E) of 0.21 which may suggest the company is not taking enough advantage from borrowing. Diagnostic Medical Systems SA has Current Ratio of 2.33 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
March 1, 2015
Market Value
Over Valued
Downside upside
Real Value
Upside upside
Diagnostic is abnormally risky asset. Calculation of real value of Diagnostic Medical S is based on 1 month time horizon. Increasing Diagnostic Medical S time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.

Diagnostic Market Share

Diagnostic Medical Systems SA is rated below average in market capitalization category among related companies. Market capitalization of Medical Appliances and Equipment industry is currently estimated at about 3.66 Billion. Diagnostic adds roughly 15.01 Million in market capitalization claiming only tiny portion of all equities under Medical Appliances and Equipment industry.
Capitalization  Valuation  Total debt  Revenue  Workforce
Follow Diagnostic Valuation with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Diagnostic Medical S Revenue

Based on latest financial disclosure Diagnostic Medical Systems SA reported 23.51 M of revenue. This is 99.57% lower than that of the Healthcare sector, and 98.46% lower than that of Medical Appliances and Equipment industry, The Revenue for all stocks is 99.85% higher than the company.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.



Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder

Research Modules

Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management

Services And Technology

Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing

Free Investor Tools

World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis

About Us

About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities